Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03834532 · ClinicalTrials.gov registry record · NA
Living Well After Breast Surgery
A NA study of Breast Cancer Female and Stage II Breast Cancer, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT03834532: Completed NA study of Breast Cancer Female and Stage II Breast Cancer, sponsored by University of Texas at Austin.
NCT03834532 is a NA study of Breast Cancer Female and Stage II Breast Cancer that has completed, run by University of Texas at Austin. The registered enrollment target is 17 participants, below the 692-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03834532, a NA study of Breast Cancer Female and Stage II Breast Cancer, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
Decision making about whether to have breast reconstruction after mastectomy can be difficult, and previous studies have found that many women are not well informed about their options. Patient decision aids can improve decision quality for a variety of health conditions. This pilot randomized study seeks to determine how a patient decision aid about breast reconstruction affects the quality of decisions about reconstruction including patient knowledge, concordance between preferences and treatment, and decisional regret.
Primary Outcome
To determine the feasibility of recruiting eligible patients and delivering the breast reconstruction decision support intervention. Measured by the number of patients enrolled per month.
Conditions Studied
Interventions
- OTHER Breast reconstruction decision aid
- OTHER Educational website
Study Locations (1)
Texas
- Texas Oncology - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-02-18 |
| Est. Completion | 2021-06-11 |
| Phase | NA |
What the finished NCT03834532 record still lists
NCT03834532 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 692-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (98% lower).
The record links to 7 conditions, with Breast Cancer Female appearing as the primary indexed condition, and to 2 interventions - of which Breast reconstruction decision aid is the first listed.
NCT03834532 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03834532 about?
NCT03834532 is a clinical study titled "Living Well After Breast Surgery". Decision making about whether to have breast reconstruction after mastectomy can be difficult, and previous studies have found that many women are not well informed about their options. Patient decision aids can improve decision quality for a variety of health conditions. This pilot randomized study...
What is the current status of trial NCT03834532?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2019-02-18. Estimated completion is 2021-06-11.
What conditions does trial NCT03834532 study?
This clinical trial studies the following conditions: Breast Cancer Female, Stage II Breast Cancer, Stage III Breast Cancer, Ductal Carcinoma In Situ, Stage I Breast Cancer.
What interventions are being tested in trial NCT03834532?
The interventions under investigation include: Breast reconstruction decision aid (OTHER), Educational website (OTHER).
Who is sponsoring clinical trial NCT03834532?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03834532 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03834532's enrollment target sits among peer trials
17 44th of 46 higher than 3 of 46 other Breast Cancer Female trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer Female trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Breast Cancer Resiliency Through Exercise Program (B-REP)
RECRUITING · NA
-
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
RECRUITING · NA
-
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
RECRUITING · NA
-
Cognitive Rehabilitation Following Breast Cancer Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI